Cipher rockets on Ranbaxy US win for Isotretinoin drug; launching 4Q
This article was originally published in Scrip
Executive Summary
Indian drug maker Ranbaxy Laboratories won the US FDA's OK to market Absorica, a patented formulation of isotretinoin, as a treatment for severe recalcitrant nodular acne.